Jun 25, 2024 8:00am EDT Ensysce Biosciences Announces Partnership to Scale and Manufacture New Drug Candidate
Jun 06, 2024 8:00am EDT Ensysce Biosciences Announces Major Milestone for Opioid Use Disorder Program
May 20, 2024 8:00am EDT Ensysce Biosciences Continues Collaboration to Advance the Clinical Development of Innovative Overdose Protection Platform
Apr 25, 2024 8:00am EDT Ensysce Biosciences’ CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical Edge Magazine
Apr 19, 2024 8:00am EDT Ensysce Biosciences' Presentation from the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference Published
Apr 09, 2024 8:00am EDT Ensysce Biosciences to Participate in the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference